We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHCO icon
2051
AdaptHealth
AHCO
$1.5B
$1.21M ﹤0.01%
101,698
+21,639
+27% +$221K
HCI icon
2052
HCI Group
HCI
$2.31B
$1.21M ﹤0.01%
7,812
+1,791
+30% +$293K
SD icon
2053
SandRidge Energy
SD
$500M
$1.21M ﹤0.01%
73,960
-199
-0.3% -$3.22K
OGN icon
2054
Organon & Co
OGN
$3.56B
$1.21M ﹤0.01%
201,132
+34,011
+20% +$256K
WS icon
2055
Worthington Steel
WS
$1.82B
$1.2M ﹤0.01%
39,660
+6,710
+20% +$260K
VPG icon
2056
Vishay Precision Group
VPG
$1.14B
$1.2M ﹤0.01%
27,683
-1,188
-4% -$53.7K
SHEN icon
2057
Shenandoah Telecom
SHEN
$649M
$1.2M ﹤0.01%
77,838
+9,712
+14% +$127K
SAH icon
2058
Sonic Automotive
SAH
$3.53B
$1.19M ﹤0.01%
17,407
+2,783
+19% +$174K
MBIN icon
2059
Merchants Bancorp
MBIN
$2.52B
$1.19M ﹤0.01%
27,778
+3,764
+16% +$153K
CABA icon
2060
Cabaletta Bio
CABA
$447M
$1.19M ﹤0.01%
442,277
-651,682
-60% -$1.81M
IJK icon
2061
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
$1.19M ﹤0.01%
11,830
-7,870
-40% -$808K
USPH icon
2062
US Physical Therapy
USPH
$1.22B
$1.19M ﹤0.01%
15,856
+2,732
+21% +$224K
APPN icon
2063
Appian
APPN
$2.07B
$1.19M ﹤0.01%
49,226
+7,353
+18% +$200K
TGLS icon
2064
Tecnoglass
TGLS
$2.02B
$1.18M ﹤0.01%
26,493
+4,891
+23% +$236K
BORR
2065
Borr Drilling
BORR
$1.19B
$1.18M ﹤0.01%
204,262
+53,348
+35% +$273K
ICHR icon
2066
Ichor Holdings
ICHR
$2.28B
$1.18M ﹤0.01%
25,293
+5,445
+27% +$212K
PDM
2067
Piedmont Realty Trust
PDM
$1.26B
$1.18M ﹤0.01%
178,728
+43,043
+32% +$335K
SGRY icon
2068
Surgery Partners
SGRY
$2.05B
$1.17M ﹤0.01%
98,414
+11,768
+14% +$169K
ACT icon
2069
Enact Holdings
ACT
$6.76B
$1.17M ﹤0.01%
28,619
+7,077
+33% +$289K
FTRE icon
2070
Fortrea Holdings
FTRE
$1.98B
$1.17M ﹤0.01%
123,819
+10,835
+10% +$139K
GAMB
2071
DELISTED
Gambling.com
GAMB
$1.17M ﹤0.01%
300,190
+22,471
+8% +$101K
CCOI icon
2072
Cogent Communications
CCOI
$601M
$1.17M ﹤0.01%
61,810
+10,512
+20% +$232K
EFG icon
2073
iShares MSCI EAFE Growth ETF
EFG
$16.2B
$1.16M ﹤0.01%
10,449
NEO icon
2074
NeoGenomics
NEO
$2.02B
$1.16M ﹤0.01%
156,118
+32,188
+26% +$339K
AZTA icon
2075
Azenta
AZTA
$1.32B
$1.16M ﹤0.01%
54,781
+12,781
+30% +$382K

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.